0001493152-24-007505 Sample Contracts

Amendment to the September 29, 2022 Employment Agreement between Celularity Inc. and Adrian Kilcoyne
Employment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations

This Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and Adrian Kilcoyne, MD (“Executive”) (collectively the “Parties”).

Sample 1
AutoNDA by SimpleDocs
Amendment to the April 1, 2022 Amended and Restated Employment Agreement between Celularity Inc. and David Beers
Employment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations

This Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and David Beers (“Executive”) (collectively the “Parties”).

Sample 1
Amendment to the July 13, 2022 Employment Agreement between Celularity Inc. and K. Harold Fletcher
Amendment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations

This Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and K. Harold Fletcher (“Executive”) (collectively the “Parties”).

Sample 1
Amendment to the April 1, 2022 Amended and Restated Employment Agreement between Celularity Inc. and Stephen Brigido
Employment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations

This Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and Stephen A. Brigido, DPM (“Executive”) (collectively the “Parties”).

Sample 1
Amendment to the April 1, 2022 Amended and Restated Employment Agreement between Celularity Inc. and John Haines
Employment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations

This Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and John R. Haines (“Executive”) (collectively the “Parties”).

Sample 1
Second Amendment to the January 7, 2021 Amended and Restated Employment Agreement between Celularity Inc. and Robert J. Hariri, MD PhD
Amendment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations

This Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and Robert J. Hariri, MD, PhD (“Executive”) (collectively the “Parties”).

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!